Previous 10 | Next 10 |
Genocea Biosciences ( GNCA ) presented some outstanding immunogenicity data at the American Society for Clinical Oncology ((ASCO)) 2019 medical meeting. It highlighted initial data from its phase 1/2a study using its neoantigen vaccine GEN-009. While this was just immunogenicity data, it was...
Introduction Every year the Russell Indexes are rebalanced to bring in new stocks and remove underperforming stocks. The FTSE Russell calls this event the annual reconstitution process, and it begins with evaluations in May and moves to the selection process on June 7th with the newly recons...
Risk comes from not knowing what you're doing. - Warren Buffett In researching a lead for Integrated BioSci Investing members, I uncovered an interesting vaccine innovator known as Genocea Biosciences ( GNCA ). Due to the company's robust data presented at the 2019 Annual Meeting of the ...
Gainers: ReWalk Robotics (NASDAQ: RWLK ) +126% . Genocea Biosciences (NASDAQ: GNCA ) +14% . Dean Foods (NYSE: DF ) +13% . RAVE Restaurant Group (NASDAQ: RAVE ) +11% . Medley Management (NYSE: MDLY ) +10% . Neon Therapeutics (NASDAQ: NTGN ) +10% . Allena Pharmaceuticals (NASDAQ:...
Vislink Technologies (NASDAQ: VISL ) -25% . More news on: Vislink Technologies, Inc., Box, Inc., Alexco Resource Corp., Stocks on the move, Read more ...
Investment thesis Genocea Biosciences ( GNCA ) is a clinical-stage biopharmaceutical initially focused on vaccine development for herpes simplex virus-2 (HSV2) and Streptococcus pneumoniae or pneumococcus, using antigen discovery platform ATLAS. Clinical studies for HSV2 demonstrated some ef...
Shares of Genocea Biosciences ( GNCA ) have gained around 40% since my May 2018 Reader Inquiry piece explored the company's pivot in focus from a late-stage immunotherapy candidate for the treatment of genital herpes to the lucrative yet crowded immuno-oncology arena. So far in 2019, share...
Gainers: Genocea Biosciences (NASDAQ: GNCA ) +45% . Mirati Therapeutics (NASDAQ: MRTX ) +34% . Cypress Semiconductor (NASDAQ: CY ) +25% . ARCA biopharma (NASDAQ: ABIO ) +23% . Centrus Energy (NYSEMKT: LEU ) +18% . Spirit MTA REIT (NYSE: SMTA ) +18% . El Paso Electric (NYSE: EE ...
Genocea Biosciences (NASDAQ: GNCA ) +94% on positive GEN-009 data in cancer patients. More news on: Genocea Biosciences, Inc., Cypress Semiconductor Corporation, Outlook Therapeutics, Inc., Stocks on the move, Read more ...
Genocea Biosciences (NASDAQ: GNCA ) reports clinical results from its ongoing Phase 1/2a trial for GEN-009, the company’s lead neoantigen vaccine candidate. More news on: Genocea Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Genocea Biosciences Inc. Company Name:
GNCA Stock Symbol:
NASDAQ Market:
Genocea Biosciences Inc. Website:
Genocea Biosciences Inc Ordinary Shares (GNCA) is expected to report for Q4 2022